Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. A key product is INOmax® (nitric oxide) gas, available through an all-inclusive offering of drug, drug-delivery systems, on-site device training, emergency deliveries and 24/7/365 technical assistance and support. To learn more, visit www.inomax.com.